{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06355531",
            "orgStudyIdInfo": {
                "id": "FNP223-CT-2301"
            },
            "organization": {
                "fullName": "Ferrer Internacional S.A.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 (Oral Formulation) to Slow the Disease Progression of Progressive Supranuclear Palsy (PSP) (PROSPER)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-assess-the-efficacy-safety-and-pharmacokinetics-of-fnp-to-slow-progression-of-progressive-supranuclear-palsy-psp"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-26",
            "studyFirstSubmitQcDate": "2024-04-03",
            "studyFirstPostDateStruct": {
                "date": "2024-04-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ferrer Internacional S.A.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "PROSPER trial is a trial to assess the efficacy of FNP-223 in slowing disease progression in participants with PSP as measured by the PSP Rating Scale (PSPRS) over 52 weeks and to assess the safety and tolerability of FNP-223 for 52 weeks in participants with PSP."
        },
        "conditionsModule": {
            "conditions": [
                "Progressive Supranuclear Palsy"
            ],
            "keywords": [
                "Progressive Supranuclear Palsy",
                "Disease progression",
                "FNP-223"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 220,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "FNP-223",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive FNP-223 orally (PO), 3 times daily (TID).",
                    "interventionNames": [
                        "Drug: FNP-223"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive matching placebo, PO, TID.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "FNP-223",
                    "description": "Oral tablets",
                    "armGroupLabels": [
                        "FNP-223"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Oral tablets",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change From Baseline to Week 52 in the PSPRS Outcome",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)",
                    "description": "Clinically significant changes in vital signs, clinical laboratory evaluations, physical examinations, and electrocardiogram (ECG) are included in TEAEs.",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Number of Participants Experiencing Serious Adverse Events (SAEs)",
                    "timeFrame": "Baseline to Week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change From Baseline to Week 52 in Clinical Global Impression of Severity Scale (CGI-S)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 Participant Global Impression of Severity Scale (PGI-S)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in Caregiver Global Impression of Severity Scale (CaGI-S)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Slope of Decline in PSPRS",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in Individual Subitems of PSPRS",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in Schwab and England Activities of Daily Living Scale",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in PSP Clinical Deficits Scale (PSP-CDS)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in Montreal Cognitive Assessment (MoCA)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Change From Baseline to Week 52 in PSP Quality of Life Scale (PSP-QoL)",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Pharmacokinetic characterization of FNP-223",
                    "description": "Mean plasma concentration of FNP-223.",
                    "timeFrame": "At Week 4 and Week 16"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female participants aged 50 to 80 years, inclusive, at the time of informed consent.\n* Diagnosis of possible or probable PSP of the Richardson's Syndrome (PSP-RS) phenotypes according to the Movement Disorders Society's Progressive Supranuclear Palsy (MDS PSP) clinical features criteria. At least 1 (either 1 or both) of the following 2 items must be met:\n\n  1. Vertical supranuclear gaze palsy.\n  2. Slowing of vertical saccades AND postural instability with falls within the first 3 years of PSP symptoms.\n* Presence of PSP symptoms \u22643 years.\n* Full 28-item PSPRS score \u226440.\n* Able to ambulate independently or with minimal assistance defined as the ability to take at least 10 steps (stabilization of 1 arm \\[ie, use of cane\\]).\n* Body weight range \u226543 kg/95 lbs to \u2264120 kg/265 lbs.\n* Reside outside a skilled nursing facility or dementia care facility.\n* Has a caregiver or study partner who will accompany them to the study visits. The caregiver or study partner must be a person who has frequent contact (at least 7 hours per week at 1 time or in different days) with the participant and is able to provide information about the participant's medication and overall condition. Prior to the conduct of any study procedures, the caregiver or study partner must be willing to sign the independent ethics committee (IEC)/institutional review board (IRB) approved informed consent.\n\nExclusion Criteria:\n\nNon-PSP- RS Movement Disorders or other central nervous system (CNS) Diseases\n\n* Score of 3 on any functional domain in the PSP-CDS.\n* Participants with known genetic mutation (based on familiar or clinical history).\n* Evidence of other neurological disorder that could explain signs of PSP (eg, Parkinson's disease, Alzheimer disease, etc.).\n* Brain magnetic resonance imaging (MRI) within 1 year of screening consistent with:\n* Primary degenerative diseases other than PSP.\n\nProcedures\n\n* For the optional substudy only: Contraindication or refusal to undergo 2 lumbar punctures for obtaining CSF.\n* Contraindication or inability to tolerate MRI for volumetric brain MRI assessments throughout the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ferrer MedInfo",
                    "role": "CONTACT",
                    "phone": "+34 609 850 565",
                    "email": "medinfo@ferrer.com"
                }
            ],
            "locations": [
                {
                    "facility": "The Neurology Center of Southern California - Carlsbad",
                    "status": "RECRUITING",
                    "city": "Carlsbad",
                    "state": "California",
                    "zip": "92011",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Angela Sutherland",
                            "role": "CONTACT",
                            "email": "angela@profoundresearch.io"
                        },
                        {
                            "name": "Irene Oh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.15809,
                        "lon": -117.35059
                    }
                },
                {
                    "facility": "Rocky Mountain Movement Disorders Center",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80113",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alyssa Andreen",
                            "role": "CONTACT",
                            "email": "a.andreen@cenexel.com"
                        },
                        {
                            "name": "Rajeev Kumar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Quest Research Institute",
                    "status": "RECRUITING",
                    "city": "Farmington Hills",
                    "state": "Michigan",
                    "zip": "48334",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Morgott",
                            "role": "CONTACT",
                            "email": "sarah.morgott@questri.com"
                        },
                        {
                            "name": "Aaron Ellenbogen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.48531,
                        "lon": -83.37716
                    }
                },
                {
                    "facility": "Central Texas Neurology Consultants",
                    "status": "RECRUITING",
                    "city": "Round Rock",
                    "state": "Texas",
                    "zip": "78681",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Koni Lopez",
                            "role": "CONTACT",
                            "email": "k.lopez@ctncpa.org"
                        },
                        {
                            "name": "Elizabeth Peckham, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.50826,
                        "lon": -97.6789
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010243",
                    "term": "Paralysis"
                },
                {
                    "id": "D000013494",
                    "term": "Supranuclear Palsy, Progressive"
                },
                {
                    "id": "D000018450",
                    "term": "Disease Progression"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000009886",
                    "term": "Ophthalmoplegia"
                },
                {
                    "id": "D000015835",
                    "term": "Ocular Motility Disorders"
                },
                {
                    "id": "D000003389",
                    "term": "Cranial Nerve Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20559",
                    "name": "Disease Progression",
                    "asFound": "Progression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13157",
                    "name": "Paralysis",
                    "asFound": "Palsy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16275",
                    "name": "Supranuclear Palsy, Progressive",
                    "asFound": "Progressive Supranuclear Palsy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12817",
                    "name": "Ophthalmoplegia",
                    "relevance": "LOW"
                },
                {
                    "id": "M18386",
                    "name": "Ocular Motility Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6605",
                    "name": "Cranial Nerve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4741",
                    "name": "Progressive Supranuclear Palsy",
                    "asFound": "Progressive Supranuclear Palsy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}